Xenon Pharmaceuticals Inc (XENE)
41.09
+1.08
(+2.70%)
USD |
NASDAQ |
Apr 23, 16:00
41.07
-0.02
(-0.05%)
After-Hours: 20:00
Xenon Pharmaceuticals Cash from Financing (Quarterly): 324.01M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 324.01M |
| September 30, 2023 | 29.51M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.006M |
| September 30, 2022 | 0.699M |
| June 30, 2022 | 269.89M |
| March 31, 2022 | 7.876M |
| December 31, 2021 | 323.95M |
| September 30, 2021 | 4.758M |
| June 30, 2021 | 0.111M |
| March 31, 2021 | 118.72M |
| December 31, 2020 | 0.045M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -16.72M |
| March 31, 2020 | 102.47M |
| December 31, 2019 | 27.43M |
| September 30, 2019 | 0.018M |
| June 30, 2019 | 0.011M |
| March 31, 2019 | 0.058M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.034M |
| September 30, 2018 | 77.43M |
| June 30, 2018 | 34.01M |
| March 31, 2018 | 0.119M |
| December 31, 2017 | 6.893M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.003M |
| March 31, 2017 | 0.174M |
| December 31, 2016 | 0.048M |
| September 30, 2016 | 23.83M |
| June 30, 2016 | 0.038M |
| March 31, 2016 | 0.044M |
| December 31, 2015 | 0.038M |
| September 30, 2015 | 0.027M |
| June 30, 2015 | 0.086M |
| March 31, 2015 | 0.127M |
| December 31, 2014 | 42.42M |
| September 30, 2014 | -0.569M |
| June 30, 2014 | -0.333M |
| March 31, 2014 | -0.393M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-16.72M
Minimum
Jun 2020
324.01M
Maximum
Dec 2023
62.78M
Average
0.699M
Median
Sep 2022
Cash from Financing (Quarterly) Benchmarks
| Acasti Pharma Inc | 0.00 |
| Aurinia Pharmaceuticals Inc | -5.577M |
| Edesa Biotech Inc | 0.3057M |
| Lexaria Bioscience Corp | 3.453M |
| ESSA Pharma Inc | 0.1967M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.46M |
| Cash from Investing (Quarterly) | -239.73M |
| Free Cash Flow | -150.94M |
| Free Cash Flow Per Share (Quarterly) | -0.508 |
| Free Cash Flow Yield | -5.49% |